// App-Quantinova.ai

3522 : Population estimates of prostate cancer risk and prognosis for carriers of germline pathogenic variants in disease implicated genes, using 200,000 UK Biobank whole exomes

Researchers

Presenter

  • Niedzica Camacho

Principal Investigators

  • Liqin Dong

  • Athena Matakidou

Medical Centers

  • AstraZeneca, Melbourn, Royston, Hertfordshire, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Prostate cancer

Biomarkers

  • Breast cancer type 2 susceptibility protein

  • PDZ And LIM Domain 7

  • checkpoint kinase 2

  • Homeobox B13

  • Partner and localizer of BRCA2

  • Ataxia-telangiectasia mutated

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved